Skip to content

A clinical trail to study the effects of drug tamreshwar vati in patients with multiple lipomas.

Clinical study on the efficacy of Tamreshwarvati in Medoj Granthi w.s.r to lipoma - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/060990
Enrollment
30
Registered
2024-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Sponsors

Dr snehal patel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.History of occurrence of lipomas less than 15 years 2.Non infective lipomas. 3.multiple lipomas.

Exclusion criteria

Exclusion criteria: 1. History of occurrence of lipomas more than 15 years 2. Patients having age below 20 years and above 60 years 3. Solitary, Infective and having family history of lipomas 4. Lipomas associated with other types of growths like fibroid, neurofibroma, lymph adenomas, malignancy etc. 5. Diabetes mellitus, Heart diseases Malnutrition, Anemia, Hypertensive 6. Patient having other systemic pathology(TB, HIV/AIDS, HbsAG, VDRL REACTIVE) 7. Pregnancy and lactating Mothers

Design outcomes

Primary

MeasureTime frame
1.reduces the size of multiple lipomas.Timepoint: Assessment done on baseline visit(day0) and after 2weeks of treatment

Secondary

MeasureTime frame
1.the external appearance of growth reduces and make patent feel confident about his skinTimepoint: Assessment done on base line and after 4weeks of treatment

Countries

India

Contacts

Public ContactDr N Sridhar

Dr BRKR Government ayurvedic college, Hyderabad, Hyderabad

pgstdepartment@gmail.com8309158194

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026